celiprolol has been researched along with Coronary Disease in 31 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It can be concluded that subjects with moderate hypercholesterolemia and hypertension benefit more from lipid-lowering treatment with simvastatin than from blood pressure-lowering with beta blocker celiprolol." | 9.12 | Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study). ( Kalliomäki, T; Makkonen, N; Olkinuora, JT; Vanhanen, H; Viikari, J, 2006) |
| "In the present study, the beta-receptor-blocker Celiprolol was tested for its antianginal effects during an observation period of 12 months; 29 patients, both male and female, with definite coronary heart diseases, were subjected to this study." | 7.67 | [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period]. ( Klinger, D, 1987) |
| "Celiprolol is a 'third generation' beta-blocking agent which is claimed to avoid problems associated with simpler beta-blockers, such as vasoconstriction, bronchoconstriction and myocardial depression." | 6.67 | Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol. ( Franz, N; Heublein, B; Modersohn, D; Panzner, B, 1991) |
| "It can be concluded that subjects with moderate hypercholesterolemia and hypertension benefit more from lipid-lowering treatment with simvastatin than from blood pressure-lowering with beta blocker celiprolol." | 5.12 | Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study). ( Kalliomäki, T; Makkonen, N; Olkinuora, JT; Vanhanen, H; Viikari, J, 2006) |
| "The cardiovascular effects of celiprolol in healthy subjects and in those with cardiovascular disease and hypertension are reviewed." | 4.77 | The central and peripheral hemodynamics of celiprolol. ( Mancia, G, 1988) |
| "To determine the effect of strong analgesics on electrical instability (vulnerability to ventricular fibrillation), we examined the action of fentanyl (60 micrograms/kg), sufentanil (10 micrograms/kg) and carfentanil (3 micrograms/kg) on the ventricular fibrillation threshold (VFT) in a dog model of coronary artery occlusion." | 3.67 | The antifibrillatory effect of fentanyl, sufentanil and carfentanil in the acute phase of local myocardial ischaemia in the dog. ( Fejfar, Z; Hess, L; Vrana, M; Vranova, Z, 1989) |
| "In the present study, the beta-receptor-blocker Celiprolol was tested for its antianginal effects during an observation period of 12 months; 29 patients, both male and female, with definite coronary heart diseases, were subjected to this study." | 3.67 | [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period]. ( Klinger, D, 1987) |
| "Celiprolol is a 'third generation' beta-blocking agent which is claimed to avoid problems associated with simpler beta-blockers, such as vasoconstriction, bronchoconstriction and myocardial depression." | 2.67 | Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol. ( Franz, N; Heublein, B; Modersohn, D; Panzner, B, 1991) |
| "Celiprolol is a novel cardioselective beta-blocking agent with attributed cardio-stimulating properties." | 2.66 | Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease. ( Frais, MA; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1986) |
| " These data suggest improvements in cardiac function from the combination of celiprolol and nitrate therapy which were not achieved by either agent when used as monotherapy; they afford an interesting insight into the manner in which such widely utilised therapeutic modalities interact in coronary artery disease." | 2.66 | A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease. ( Frais, MA; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1986) |
| "A new cardioselective betablocker, celiprolol (C) in a dosage of 100 mg t." | 2.65 | [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ]. ( Brandt, D; Fluch, N; Klein, W, 1982) |
| "Celiprolol has been shown in preclinical studies to be a beta 1-selective antagonist with bronchosparing and vasodilating properties, but without any cardiodepressant effect." | 1.27 | Acute hemodynamic effects of celiprolol. ( Donaldson, RM; Lee, EH; Williams, LA, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (61.29) | 18.7374 |
| 1990's | 9 (29.03) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K | 1 |
| Kashihara, H | 1 |
| Hosozawa, KI | 1 |
| Tamura, M | 1 |
| Baba, S | 1 |
| Iwasaki, Y | 1 |
| Olkinuora, JT | 1 |
| Viikari, J | 1 |
| Vanhanen, H | 1 |
| Makkonen, N | 1 |
| Kalliomäki, T | 1 |
| Klein, W | 1 |
| Fluch, N | 1 |
| Brandt, D | 1 |
| Rameis, H | 1 |
| Cleophas, TJ | 1 |
| van 't Leven, M | 1 |
| Kauw, FH | 1 |
| Remmert, HP | 1 |
| Kuijper, A | 1 |
| Zwinderman, K | 1 |
| Modersohn, D | 2 |
| Franz, N | 2 |
| Heublein, B | 2 |
| Panzner, B | 2 |
| Walde, T | 1 |
| Bruch, L | 1 |
| Schweizer, J | 1 |
| Kaulen, R | 1 |
| Altmann, E | 1 |
| Nierade, A | 1 |
| Nanning, T | 1 |
| Jost, S | 1 |
| Hausmann, D | 1 |
| Lippolt, P | 1 |
| Sturm, M | 1 |
| Owens, P | 1 |
| O'Brien, E | 1 |
| Burger, W | 1 |
| Hampel, C | 1 |
| Kaltenbach, M | 1 |
| Hartmann, A | 1 |
| Herrmann, M | 1 |
| Hoffmann, JA | 1 |
| Klepzig, H | 1 |
| Frishman, WH | 1 |
| Dargie, HJ | 1 |
| Grant, S | 1 |
| McLenachan, J | 1 |
| Strein, K | 1 |
| Sponer, G | 1 |
| Estes, NA | 1 |
| Lin, SK | 1 |
| Caruso, FS | 2 |
| Solomon, TA | 1 |
| Silke, B | 3 |
| Verma, SP | 3 |
| Frais, MA | 3 |
| Reynolds, G | 3 |
| Taylor, SH | 4 |
| Gensini, G | 2 |
| Dator, C | 2 |
| Esente, P | 1 |
| Solomon, T | 2 |
| Douard, H | 1 |
| Koch, M | 1 |
| Laporte, T | 1 |
| Abella, ML | 1 |
| Provendier, O | 1 |
| Broustet, JP | 1 |
| Hess, L | 1 |
| Vrana, M | 1 |
| Vranova, Z | 1 |
| Fejfar, Z | 1 |
| Barrett, JA | 1 |
| Magistro, AM | 1 |
| Smith, RD | 1 |
| Pruss, TP | 1 |
| Wolf, PS | 1 |
| Caruso, F | 1 |
| Hitzenberger, G | 1 |
| Leisch, F | 1 |
| Herbinger, W | 1 |
| Klinger, D | 1 |
| Málek, I | 1 |
| Uhlír, O | 1 |
| Hammer, J | 1 |
| Kasalický, J | 1 |
| Vojácek, J | 1 |
| Fabián, J | 1 |
| Mancia, G | 1 |
| Donaldson, RM | 1 |
| Williams, LA | 1 |
| Lee, EH | 1 |
| Valentin, A | 1 |
| Karnik, R | 1 |
| Kaspar, L | 1 |
| Slany, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "PGDT With the Hypotension Prediction Index to Reduce the Number and Duration of Intraoperative Hypotension and the Incidence of Renal Failure in Patients Undergoing Lung Surgery"[NCT04149314] | 142 participants (Actual) | Interventional | 2019-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for celiprolol and Coronary Disease
| Article | Year |
|---|---|
Clinical perspective on celiprolol: cardioprotective potential.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Asthma; Blood Pressure; Celiprolol; Coronary Disease; | 1991 |
Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Celiprolol; Coronary Disease; Heart Fa | 1990 |
The central and peripheral hemodynamics of celiprolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Celiprolol; Coronary Disease; Hemodynamics; Hu | 1988 |
14 trials available for celiprolol and Coronary Disease
| Article | Year |
|---|---|
Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study).
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Celiprolol; Coronary Disease; Drug Therapy, | 2006 |
[Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Celiprolol; Clinical Trials as Topic; | 1982 |
Celiprolol and propranolol for unstable angina pectoris.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angina, Unstable; Celiprolol; Coronary Disease | 1995 |
Acute influence of beta-adrenergic antagonists on left ventricular diastolic function: contrasting results after administration of celiprolol and metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Celiprolol; Coronary Disease; Double-Blind Method; Heart; Humans | 1994 |
[Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?].
Topics: Adrenergic beta-Antagonists; Aged; Arterial Occlusive Diseases; Atenolol; Blood Flow Velocity; Celip | 1996 |
Acute effects of celiprolol on angiographically normal and stenotic coronary arteries.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Celiprolol; Coronary Angiography; Coronary | 1997 |
Effect of atenolol and celiprolol on acetylcholine-induced coronary vasomotion in coronary artery disease.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Atenolol; Celiprolol; Coronary Disease; Coronary Vessels | 2000 |
Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Cardiac Output; Celiprolol; Coronary Disease | 1991 |
Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Celiprolol; Coronary Circulation; Coronary Disease; Double-Blind | 1991 |
Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Celiprolol; Coronary Disease; Exercise Test; Female; Heart; H | 1986 |
Comparison of the acute hemodynamic effects of intravenous celiprolol and propranolol in patients with suspected coronary disease.
Topics: Adult; Cardiac Catheterization; Celiprolol; Coronary Disease; Female; Hemodynamics; Humans; Male; Mi | 1986 |
Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Celiprolol; Coronary Disease; Drug Synergism; Dru | 1989 |
A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Coronary Disease; Drug Therapy, Combination; E | 1986 |
[Modification of the autonomic vascular reaction and peripheral circulation in the handgrip and orthostasis test by beta-blockage in patients with and without peripheral arterial occlusive disease].
Topics: Adult; Aged; Arousal; Arterial Occlusive Diseases; Blood Pressure; Celiprolol; Clinical Trials as To | 1988 |
14 other studies available for celiprolol and Coronary Disease
| Article | Year |
|---|---|
Concurrent dolichoectasia of basilar and coronary arteries.
Topics: Age of Onset; Aged; Aged, 80 and over; Antihypertensive Agents; Basilar Artery; Celiprolol; Coronary | 2006 |
[New drugs registered in Austria. Selectol].
Topics: Adrenergic beta-Antagonists; Animals; Austria; Celiprolol; Coronary Disease; Dogs; Drug Interactions | 1984 |
Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Amb | 1999 |
Clinical cardiac electrophysiologic study of celiprolol.
Topics: Adult; Aged; Bundle of His; Celiprolol; Coronary Disease; Electrocardiography; Electrophysiology; Fe | 1986 |
The antifibrillatory effect of fentanyl, sufentanil and carfentanil in the acute phase of local myocardial ischaemia in the dog.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Animals; Celiprolol; Coronary Disease; Dogs; Fentan | 1989 |
Celiprolol, a compound which attenuates myocardial acidosis and improves regional segmental function following ischemia in dogs: a comparison with propranolol.
Topics: Acidosis; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Body Temperature; Cardiomyopathies; | 1989 |
Celiprolol: a haemodynamic appraisal in comparison with propranolol.
Topics: Adrenergic beta-Antagonists; Celiprolol; Coronary Disease; Drug Evaluation; Female; Hemodynamics; Hu | 1985 |
Comparative effects of celiprolol and metoprolol on left ventricular volume in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Celiprolol; Coronary Disease; Humans; Metoprolol; Propanolamines; Strok | 1985 |
The cardiovascular effects of celiprolol in healthy volunteers and patients with coronary heart disease.
Topics: Adrenergic beta-Antagonists; Celiprolol; Coronary Disease; Hemodynamics; Humans; Male; Physical Exer | 1985 |
[Hemodynamic effects of intravenously administered celiprolol in patient with coronary heart disease and depressed left ventricular function].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Coronary Disease; Heart Ventricles; Hemodynami | 1987 |
[Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Celiprolol; Coronary Disease; Electrocard | 1987 |
Celiprolol and the heart.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cardiac Output; Celiprolol; Coronary Disease; | 1988 |
[Celiprolol tolerance in patients with left ventricular function disorders].
Topics: Adrenergic beta-Antagonists; Aged; Celiprolol; Coronary Disease; Heart Ventricles; Humans; Male; Mid | 1988 |
Acute hemodynamic effects of celiprolol.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Celiprolol; Coronary Disease; Female; Heart; H | 1988 |